NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,657,833 | +115107.3% | 165,391 | +24.8% | 0.03% | -11.1% |
| Q1 2023 | $2,307 | +118.7% | 132,502 | +16.0% | 0.04% | +71.4% |
| Q4 2022 | $1,055 | -99.8% | 114,209 | +106.0% | 0.02% | +110.0% |
| Q3 2022 | $477,000 | +58.5% | 55,430 | +123.8% | 0.01% | +42.9% |
| Q1 2022 | $301,000 | -43.3% | 24,768 | +125.2% | 0.01% | -36.4% |
| Q1 2021 | $531,000 | -45.9% | 11,000 | -85.9% | 0.01% | -42.1% |
| Q4 2018 | $982,000 | +42.1% | 77,896 | +73.1% | 0.02% | +11.8% |
| Q3 2018 | $691,000 | +26.8% | 45,012 | +8.4% | 0.02% | -10.5% |
| Q2 2018 | $545,000 | +306.7% | 41,542 | +153.6% | 0.02% | +375.0% |
| Q1 2018 | $134,000 | -62.8% | 16,380 | -64.1% | 0.00% | -63.6% |
| Q1 2017 | $360,000 | +56.5% | 45,632 | +69.8% | 0.01% | +83.3% |
| Q4 2016 | $230,000 | +155.6% | 26,870 | +145.5% | 0.01% | +200.0% |
| Q3 2016 | $90,000 | -21.1% | 10,943 | -22.8% | 0.00% | 0.0% |
| Q2 2016 | $114,000 | – | 14,179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |